Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sean O'Quinn"'
Autor:
Donald Stull, Sean O’Quinn, Betsy Williams, Stephanie Bean, Erik Schwetje, Gabriel Abreu, Raj Tummala
Publikováno v:
Rheumatology. 61:4731-4740
Objectives SLE significantly impairs health-related quality of life (HRQoL). In this post hoc analysis, structural equation modelling was used to examine the ‘causal cascade’ of interaction between anifrolumab, disease activity and patient-report
Autor:
Vibeke Strand, Sean O’Quinn, Richard A Furie, Eric F Morand, Kenneth C Kalunian, Erik G Schwetje, Gabriel Abreu, Raj Tummala
Publikováno v:
The Lancet Rheumatology. 4:e198-e207
Autor:
Sean O'Quinn, Vivian H. Shih, Ubaldo J. Martin, Oren Meyers, Patrick Crooks, Julie Bailey, Ashley F. Slagle
Publikováno v:
International Forum of Allergy & Rhinology. 12:996-1005
This qualitative study assessed the experience of patients with chronic rhinosinusitis with nasal polyposis (NP) to inform the development of a novel symptom diary for clinical study use.Concept elicitation and cognitive interviews were conducted wit
Autor:
Esther Garcia Gil, Jane R. Parnes, Jonathan Corren, Rene van der Merwe, Janet M. Griffiths, Kinga Sałapa, Sean O'Quinn
Publikováno v:
Annals of Allergy, Asthma & Immunology. 126:187-193
Background Patients with severe, uncontrolled asthma experience frequent exacerbations and hospitalization, leading to poor health-related quality of life. In the phase 2b PATHWAY study (NCT02054130), tezepelumab reduced exacerbations by up to 71% an
Autor:
Adam Gater, Linda Nelsen, Cheryl D. Coon, Sonya Eremenco, Sean O’Quinn, Asif H. Khan, Laurent Eckert, Hannah Staunton, Nicola Bonner, Rebecca Hall, Jerry A. Krishnan, Stuart Stoloff, Michael Schatz, John Haughney, Stephen Joel Coons
Publikováno v:
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
BACKGROUND: The Asthma Daytime Symptom Diary (ADSD) and the Asthma Nighttime Symptom Diary (ANSD) were developed to meet the need for standardized patient-reported measures of asthma symptoms to assess treatment trial outcomes in adults and adolescen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b9d2b63442bf16c52f200f677f8542c
https://hdl.handle.net/1854/LU-8747116
https://hdl.handle.net/1854/LU-8747116
Autor:
Christopher S. Ambrose, Wendy C. Moore, Frank Trudo, Bradley E. Chipps, Reynold A. Panettieri, W. Carr, James Kreindler, Weily Soong, Sean O'Quinn
Publikováno v:
Chest. 156:A1652-A1655
Autor:
Reynold Panettieri, Bradley Chipps, Wendy Moore, Weily Soong, Warner Carr, James Kreindler, Sean O'Quinn, Frank Trudo, Christopher Ambrose
Publikováno v:
Chest. 156:A211-A214
Autor:
Catherine Datto, Julie Bailey, Oren Meyers, Ashley F. Slagle, Evan S. Dellon, Sean O'Quinn, Calvin N. Ho
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-9 (2021)
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-9 (2021)
Background A patient reported outcome (PRO) instrument with evidence of validity and reliability for assessing symptoms of eosinophilic gastritis (EG) and eosinophilic gastroenteritis (EGE) is needed to measure treatment benefit in clinical trials. T
Autor:
Christopher S. Ambrose, Jennifer Trevor, Sean O'Quinn, Frank Trudo, W. Carr, Bradley E. Chipps, Laura Belton, Weily Soong
Publikováno v:
Journal of Asthma and Allergy
Weily Soong,1 Bradley E Chipps,2 Sean OâQuinn,3 Jennifer Trevor,4 Warner W Carr,5 Laura Belton,6 Frank Trudo,7 Christopher S Ambrose3 1Alabama Allergy & Asthma Center, Birmingham, AL, USA; 2Capital Allergy & Respiratory Disease Center, Sacrament
Publikováno v:
Journal of Asthma and Allergy
Sean O’Quinn, Xiao Xu, Ian Hirsch AstraZeneca, Gaithersburg, MD, USA Background: Patients with severe, uncontrolled asthma experience debilitating symptoms that result in meaningful reductions to health-related quality of life. Benralizumab is an i